Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $194.63 million. The enterprise value is $36.53 million.
Important Dates
The last earnings date was Friday, November 7, 2025, after market close.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRBU has 93.12 million shares outstanding. The number of shares has increased by 4.28% in one year.
| Current Share Class | 93.12M |
| Shares Outstanding | 93.12M |
| Shares Change (YoY) | +4.28% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 4.70% |
| Owned by Institutions (%) | 41.34% |
| Float | 84.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.04 |
| Forward PS | 16.25 |
| PB Ratio | 1.17 |
| P/TBV Ratio | 1.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.66, with a Debt / Equity ratio of 0.16.
| Current Ratio | 6.66 |
| Quick Ratio | 6.46 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.93% and return on invested capital (ROIC) is -35.65%.
| Return on Equity (ROE) | -68.93% |
| Return on Assets (ROA) | -31.77% |
| Return on Invested Capital (ROIC) | -35.65% |
| Return on Capital Employed (ROCE) | -78.62% |
| Revenue Per Employee | $62,048 |
| Profits Per Employee | -$1.12M |
| Employee Count | 147 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -9,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.00% in the last 52 weeks. The beta is 2.59, so CRBU's price volatility has been higher than the market average.
| Beta (5Y) | 2.59 |
| 52-Week Price Change | -24.00% |
| 50-Day Moving Average | 2.21 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 39.84 |
| Average Volume (20 Days) | 4,676,755 |
Short Selling Information
The latest short interest is 3.67 million, so 3.94% of the outstanding shares have been sold short.
| Short Interest | 3.67M |
| Short Previous Month | 4.07M |
| Short % of Shares Out | 3.94% |
| Short % of Float | 4.37% |
| Short Ratio (days to cover) | 2.65 |
Income Statement
In the last 12 months, CRBU had revenue of $9.12 million and -$164.26 million in losses. Loss per share was -$1.79.
| Revenue | 9.12M |
| Gross Profit | -119.86M |
| Operating Income | -150.95M |
| Pretax Income | -164.27M |
| Net Income | -164.26M |
| EBITDA | -146.26M |
| EBIT | -150.95M |
| Loss Per Share | -$1.79 |
Full Income StatementBalance Sheet
The company has $183.95 million in cash and $25.85 million in debt, giving a net cash position of $158.10 million or $1.70 per share.
| Cash & Cash Equivalents | 183.95M |
| Total Debt | 25.85M |
| Net Cash | 158.10M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 166.13M |
| Book Value Per Share | 1.78 |
| Working Capital | 163.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$133.11 million and capital expenditures -$2.65 million, giving a free cash flow of -$135.77 million.
| Operating Cash Flow | -133.11M |
| Capital Expenditures | -2.65M |
| Free Cash Flow | -135.77M |
| FCF Per Share | -$1.46 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,655.02% |
| Pretax Margin | -1,801.03% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.28% |
| Shareholder Yield | -4.28% |
| Earnings Yield | -84.40% |
| FCF Yield | -69.76% |
Analyst Forecast
The average price target for CRBU is $9.33, which is 346.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.33 |
| Price Target Difference | 346.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 171.34% |
| EPS Growth Forecast (5Y) | -13.58% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRBU has an Altman Z-Score of -3.17 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.17 |
| Piotroski F-Score | 1 |
